Timothy Jinks was appointed the head of Infectious Disease Interventions at Wellcome in 2021. He leads Wellcome’s work in advancing R&D for therapeutics and diagnostics, alongside research to support solutions for antimicrobial resistance. In his previous role, he designed and led Wellcome’s strategic priority area for combatting drug-resistant infections, deploying a budget of over £250 million. Before joining Wellcome in 2012, he accumulated over a decade of industry experience both in biologic therapeutic R&D and latterly as a consultant providing business development, licensing and commercial research services.